Sabby Management, LLC
Annual return '25
+17.2%
SPY '25
+17.7%
Alpha
-0.5ptsvs SPY
Invested
—
Holdings
20
Trades YTD
0
Performance · Fund vs SPY
Cumulative return · quarterly snapshotsCoverage 98%. 3 quarters of 2025 measured against SPY adj-close benchmark.
Top holdings · current snapshot
Source: 13F-HR01
$SPY
SPDR S&P 500 ETF
Q1 2026: Increased +1532.2% (335 → 5.5k shares)
36.9%
02
$BCTXL
BRIACELL THERAPEUTICS CORP
Q1 2026: New position (761.4k shares)
8.1%
03
$SNES
SENESTECH INC
Q1 2026: Increased +107.6% (210.6k → 437.1k shares)
7.4%
04
$ALP
ALPHATON CAPITAL CORP
Q1 2026: New position (2.07M shares)
6.8%
05
$BCTX
BRIACELL THERAPEUTICS CORP
Q1 2026: New position (147.8k shares)
6.4%
06
$TC
TOKEN CAT LTD
Q1 2026: New position (46.5k shares)
5.0%
07
$MBRX
MOLECULIN BIOTECH INC
Q1 2026: New position (150.0k shares)
3.6%
08
$BDRX
BIODEXA PHARMACEUTICALS PLC
Q1 2026: Increased +170.1% (190.7k → 514.9k shares)
3.3%
09
$RKDA
ARCADIA BIOSCIENCES INC
Q1 2026: New position (229.1k shares)
3.3%
10
$TRX
TRX GOLD CORP
Q1 2026: New position (200.0k shares)
3.1%
Recent trades · Last 90 days
No Form 4 / 13D / 13G trade events on file in the recent window. 13F filers report position snapshots quarterly rather than per-trade events, so this section is most useful for managers who also file Form 4 or 13D/G.
Source data: SEC EDGAR · 13F-HR filings · Performance through 2025-12-31 · Last refreshed 09:18 UTC.